Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aleafia Health Provides Further Update on its Convertible Debt
Entered into Forbearance Agreement with Holders representing 58% of total Debentures
Negotiating a potential transaction to amend the Convertible Debt terms for all debenture holders
TORONTO – February 1, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”).
Further to the Company’s announcement on January 4, 2022, Aleafia Health is advancing towards achieving a beneficial outcome for all its stakeholders.
The Company has entered into a Forbearance Agreement (the “Forbearance Agreement”) with Debenture holders representing 58% of the Debentures’ aggregate principal amount outstanding (the “Holders”). An ad hoc Steering Committee comprised of certain Debentureholders, and represented by Bennett Jones, has been established that will help facilitate ongoing negotiations surrounding the Convertible Debt. The Forbearance Agreement’s initial term extends to February 28, 2022, and the agreement automatically renews for 14-day periods thereafter unless notice to the contrary is provided (the “Term”).
Under the Forbearance Agreement, the Holders, among other considerations, forebear in enforcing their rights or remedies against the Company under the Indenture and otherwise at law with respect to the non-payment of interest until the expiry of the Term. The Company, in turn, has agreed to certain customary and standard covenants regarding carrying on business in the ordinary course during the Term.
Under the Forbearance Agreement, the Holders and the Company have agreed to work expeditiously and in good faith to negotiate a potential transaction to amend the terms associated with the Convertible Debt. There can be no assurance that the negotiations will result in a transaction.
For Investor & Media Relations:
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
Did anyone see/read the SA piece -
<Tilray a sell at GLJ Research as firm sees 88& stock decline By: Jonathan Block, SA News Editor>
I'm out of free articles.....hit piece or any validity to it?
Good News...?!
Hexo Close To Finding A New CEO After Departure Of Sebastien St-Louis -- MarketWatch
Dow Jones Newswires October 18, 2021 07:30:00 AM ET
Hexo Corp. (HEXO.T) said Monday it's in advanced talks with "a preferred CEO candidate" and it expects to make an announcement in coming days. The company said founder and CEO Sebastien St-Louis has left the cannabis beverage company as part of a strategic reorganization. Hexo chairman Michael Munzar thanked St-Louis and said the board has set up a special committee for succession to find a new CEO to help the company defend its "position as a market leader in Canada and secure our place as a top-three global cannabis company." In a statement, St-Louis said the Hexo"future is bright" and that he looks forward to the company's next stage of growth as a significant shareholder. Hexo COO Donald Courtney has also resigned but will remain in the position until a replacement is identified. St-Louis had been with Hexo since he founded the company in 2013. HEXO shares are down 53% this year, negatively outpacing the Cannabis ETF's (THCX) 3% dip YTD.
Here it is, haven't read it yet:
https://s26.q4cdn.com/943649897/files/doc_financials/2021/q2/Fisker_Q2-2021-Earnings-Release.pdf
In Schwab POTVF is still trading under GRCU - is this happening at any other brokerage houses?
OGI : Organigram beats on revenue
6:03 am, Tue, Jul. 13, 2021
https://seekingalpha.com/pr/18391023-organigram-reports-third-quarter-fiscal-2021-results
I have a starter position and have been adding on dips - a bit worried about the delisting possibilities....holding for now.
New here....doing some DD and missed a big move today, I'll be in at the opening tomorrow, buy a little now then maybe wait for a breather.
Anyone notice any pumps going on on other msg boards...? I certainly hope not, I have a boatload of Auxly that hasn't been above water for a very long time.
Bravo Las3r!
after hours up 15+%
Doesn't make is acceptable....ask Louis C.K.
The new Crisp Protein Bars are great....they give me a little hope.
MusclePharm's (MSLP) CEO Ryan Drexler on Q4 2017 Results - Earnings Call Transcript:
https://seekingalpha.com/article/4159748-musclepharms-mslp-ceo-ryan-drexler-q4-2017-results-earnings-call-transcript?app=1&auth_param=3k42d:1dboaqv:d5c235384251e47621a3596100324a1b
couldn't get on the call...would love to hear what your thoughts are.
Does anyone have background on this?
https://ir.cocrystalpharma.com/all-sec-filings/content/0001493152-18-002151/form8-k.htm
This may be one of the reasons we tanked today:
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/aphria-seeking-alternatives-us-cannabis-assets/
Where did you see that, loved the old formula.
Wish I could be there....look forward to hearing your take on the meeting.
YAHOO Finance report on the Ford story this morning in their live finance show Market Movers:
https://finance.yahoo.com/
it is in replay now, but they might pull the EKSO story and have it as video on demand
Reverse Split in the works:
http://ir.cocrystalpharma.com/all-sec-filings/content/0001493152-17-011227/pre14c.htm
Cocrystal Pharma, HitGen and InterX Enter into Drug Discovery Collaboration
http://www.marketwired.com/press-release/cocrystal-pharma-hitgen-and-interx-enter-into-drug-discovery-collaboration-2232427.htm
Ekso Bionics® Announces Commencement of $34 Million Rights Offering
http://ir.eksobionics.com/press-releases/detail/622
Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update
http://ir.cocrystalpharma.com/press-releases/detail/37
another 8-K.....more money out the door but hopefully the last mess to clean up.
http://ir.musclepharmcorp.com/all-sec-filings/content/0001654954-17-006898/mslp_8k.htm
My stop/loss kicked in this morning....looking to get back in when it settles.
Today’s 13GD Filing: Musclepharm Corp: Ini Buyer, Inc Opened Big New Position
http://friscofastball.com/2016/11/17/todays-13gd-filing-musclepharm-corp-ini-buyer-inc-opened-big-new-position/
In case anyone wants an in-depth read......I am still nauseous.
http://www.4-traders.com/MUSCLEPHARM-CORP-15867051/news/MUSCLEPHARM--Managements-Discussion-and-Analysis-of-Financial-Condition-and-Results-of-Operations-20036263/
Has anyone seen a date yet for 2nd quarter reporting?
I have a buy order in at 7.00
Nice run up....I am currently researching this company. What is your opinion on share price going forward....room to run?
What is going on with the NASDAQ application - anyone heard anything?